Search Results
RESEARCH NEWS
April 2026 Research continues to advance across both clinical trials and early-stage discovery, offering new insights into how vision loss may be treated — and potentially even reversed. This month we highlight...
READ MOREIMPROVING AMD TREATMENTS BY STUDYING CELL MOVEMENT
Age-related macular degeneration (AMD) is the leading cause of vision loss in people over the age of 50, affecting approximately 1.4 million Canadians. There are two kinds of AMD: dry AMD which...
READ MOREBIOLOGICAL MECHANISMS DRIVING HDAC INHIBITOR TREATMENT EFFECTS IN RP
Valproic acid (VA), belongs to a family of drugs called HDAC inhibitors (HDACi) and has been tested as a potential treatment for retinitis pigmentosa (RP) with mixed results. In some clinical trials,...
READ MORENEW VISION TREATMENT MAY STOP PHOTORECEPTOR CELLS FROM DYING
FBC-funded researcher, Dr. Philippe Monnier identifies new treatment to stop photoreceptor cells from dying. Research published in March 2020 in The Journal of Clinical Investigation has identified a new target that may...
READ MOREINFORMATION ABOUT COVID-19 AND YOUR EYE HEALTH
We understand this time of uncertainty may be confusing. We have prepared answers to some questions you may have about your eye health during these times. Different levels of government and professional...
READ MORELUXTURNA TREATMENT: RESTORING VISION BECOMES A REALITY
World’s first approved gene therapy for an eye disease is turning the dream of treating inherited retinal diseases (IRD) into a reality. Forty-six years ago families came together to form Fighting Blindness...
READ MOREJoin the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.